J Breast Cancer.  2008 Sep;11(3):125-132. 10.4048/jbc.2008.11.3.125.

The Efficacy of Enoxaparin for the Prevention of a Pulmonary Thromboembolism in a Skin-sparing Mastectomy with Immediate Reconstruction in Breast Cancer

Affiliations
  • 1Department of Surgery, College of Medicine, Hanyang University, Seoul, Korea.
  • 2Department of Surgery, University of Ulsan, College of Medicine and Asan Medical Center, Seoul, Korea. brdrson@korea.com
  • 3Department of Plastic Surgery, University of Ulsan, College of Medicine and Asan Medical Center, Seoul, Korea.
  • 4Department of Pulmonology, College of Medicine Dongguk University Pohang Hospital, Pohang, Korea.
  • 5Department of Surgery, College of Medicine Dongguk University International Hospital, Goyang, Korea.

Abstract

PURPOSE
Performance of a skin-sparing mastectomy with immediate reconstruction provides psychological satisfaction and good cosmetic outcome for patients with breast cancer. However, this is a lengthy procedure to perform, and there is increased risk of pulmonary thromboembolism (PTE). The purpose of this study was to evaluate the efficiency of the use of low molecular weight heparins (enoxaparin) for prophylaxis against a pulmomary thromboembolism followed by mastectomy with an immediate transverse rectus abdominis myocutaneous flap (TRAM) in breast cancer. METHODS: A total of 123 patients underwent a skin-sparing mastectomy with an immediate TRAM. The "non-enoxaparin group" wore compression stockings for PTE prophylaxis and the "enoxaparin group" received enoxaparin (40 mg SC injection, once daily starting 2 hr before surgery and continuing for 6 days postoperatively) in conjunction with the use of compression stockings. Lung perfusion, inhalation scans, and serum D-dimer assays were performed on postoperative day 3. If findings were clinically suspicious or intermediate to high probability of a PTE in a lungs scan, embolism computed tomography was performed. Patients were prospectively investigated according to the clinicopathological data. We compared the incidence of PTE and hemorrhagic complications between the two groups. RESULTS: There were no significant clinicopathological differences between the two groups. Eleven patients developed a PTE (nine patients in the non-enoxaparin group and two patients in the enoxaparin group). The prevalence rate of a PTE was 17.3% and 3.2% for each group, respectively (p=0.01). One patient in the non-enoxaparin group required a second operation for bleeding control and three patients in the enoxaparin group needed transfusions. There were minor hemorrhagic complications in the enoxaparin group that improved after supportive management. CONCLUSION: Although there were minor hemorrhagic complications, enoxaparin is safe and effective in a preventing PTE in patients that undergo immediate reconstruction after a skin-sparing mastectomy.

Keyword

Breast cancer; Pulmonary thromboembolism; Skin sparing mastectomy; Immediate reconstruction; Enoxaprin

MeSH Terms

Breast
Breast Neoplasms
Cosmetics
Embolism
Enoxaparin
Fibrin Fibrinogen Degradation Products
Hemorrhage
Heparin, Low-Molecular-Weight
Humans
Incidence
Inhalation
Lung
Mastectomy
Perfusion
Prevalence
Prospective Studies
Pulmonary Embolism
Rectus Abdominis
Stockings, Compression
Thromboembolism
Cosmetics
Enoxaparin
Fibrin Fibrinogen Degradation Products
Heparin, Low-Molecular-Weight
Full Text Links
  • JBC
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2026 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr